Our results suggest that the effect of Gal-1 could be relevant in several physiological processes involving HERV Env proteins, such as cytotrophoblast, myoblast, and osteoclast fusion; immune tolerance during pregnancy; and pathological conditions, such as multiple sclerosis and cancer, in which these fusogenic proteins show abnormal expression. This evidence concerns the gene LGALS1 and cancer.